4//SEC Filing
PDL BIOPHARMA, INC. 4
Accession 0001140361-07-019181
CIK 0000882104operating
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 1:25 PM ET
Size
9.5 KB
Accession
0001140361-07-019181
Insider Transaction Report
Form 4
Iwanicki David
VP, Sales & Sales Operations
Transactions
- Sale
Common Stock
2007-10-02$22.58/sh−645$14,564→ 0 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2007-10-02−645→ 21,970 totalExercise: $17.13Exp: 2013-07-20→ Common Stock (645 underlying) - Exercise/Conversion
Common Stock
2007-10-02$17.13/sh+645$11,049→ 645 total
Footnotes (2)
- [F1]Sale was made pursuant to a 10b5-1 plan established by the reporting person.
- [F2]Option vests with respect to approximately 645 shares per month and 11 shares remained exercisable immediately after this transaction. Only vested options are exercisable
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000882104
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 1:25 PM ET
- Size
- 9.5 KB